The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2026

Filed:

Mar. 29, 2022
Applicant:

Ionctura SA, Geneva, CH;

Inventors:

Catherine Pickering, Geneva, CH;

Lars Van Der Veen, Geneva, CH;

Michael Lahn, Geneva, CH;

Rebeca Zorrilla, Geneva, CH;

Zoë Johnson, Geneva, CH;

Assignee:

iOnctura SA, Genèva, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61P 35/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61P 35/04 (2018.01);
Abstract

A compound or a pharmaceutically acceptable salt thereof for use in a method of treatment of a disease or condition in which signalling through the PI3Kδ pathway is pathologically implicated in patients, for example cancer and inflammatory or autoimmune diseases. The compound is provided at a specified dose and has been found to have a favourable safety profile in humans, in particular with regard to hepatotoxicity, diarrhoea/colitis, respiratory infections, and hematologic toxicities.


Find Patent Forward Citations

Pickering, Catherine. (2026). Pi3k-δ inhibitor for use in treatment regimens (U.S. Patent No. 12605389). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12605389

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…